Fund Overview
Fund
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Underlying Index: Nifty MidSmall HealthcareISIN: INF247L01EA7
12.1213.04% (1Y)
End of Day NAV as on Oct 09, 2026
Fundamentals
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 30 Companies |
| Market Cap Focus | Mid & Small Cap |
| Std Deviation (1 yr) | 0.90% |
| P/E | 63.78 |
| P/B | 8.22 |
| Div Yield | 0.38% |
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 30 |
| Market Cap Focus | Mid & Small Cap |
| P/E | 63.78 |
| P/B | 8.22 |
| Div Yield | 0.38% |
| Std Deviation (1 yr) | 0.90% |
Fund Parameters
| AUM (Cr) | 51 |
| Base Expense Ratio | 0.54% |
| Tracking Error | 0.09% |
| All-In-Cost | 0.63% |
| Inception Date | 19 Nov 2024 |
| Scheme Plan - Option - Type | Direct Plan - Growth - Open ended scheme |
Native Score
| AUM (Cr) | 51 |
| Base Expense Ratio | 0.54% |
| Tracking Error | 0.09% |
| All-In-Cost | 0.63% |
| Inception Date | 19 Nov 2024 |
| Scheme Plan - Option - Type | Direct Plan - Growth - Open ended scheme |
| Native Score |
Similar Exchange Traded Funds (ETFs)
No similar exchange traded funds (etfs) available for this index
Similar Index Funds
| Fund Name | ||||||
|---|---|---|---|---|---|---|
| N/A | 219 | 0.37% | 0.09% | 0.46% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | All-In-Cost | Score |
|---|---|---|---|---|---|---|
| N/A | 219 | 0.37% | 0.09% | 0.46% |
Sectoral Allocation
Total
100%
allocation
- Healthcare99.2%
- Business Services1.1%
- Healthcare99.2%
- Business Services1.1%
Fund Holdings
| Name | Weight |
|---|
| Laurus Labs Ltd. | 11.2% |
| Lupin Ltd. | 8.0% |
| Aurobindo Pharma Ltd. | 7.2% |
| Fortis Healthcare Ltd. | 7.1% |
| Glenmark Pharmaceuticals Ltd. | 5.6% |
| Alkem Laboratories Ltd. | 4.7% |
| Biocon Ltd. | 4.4% |
| Ipca Laboratories Ltd. | 4.1% |
| Mankind Pharma Ltd. | 4.1% |
| Gland Pharma Ltd. | 3.5% |
| Aster DM Quality Care Ltd. | 3.0% |
| Sai Life Sciences Ltd. | 3.0% |
| Neuland Laboratories Ltd. | 3.0% |
| Krishna Institute of Medical Sciences Ltd | 3.0% |
| Acutaas Chemicals Ltd. | 2.5% |
| Wockhardt Ltd. | 2.3% |
| Ajanta Pharma Ltd. | 2.3% |
| Dr. Lal Pathlabs Ltd. | 2.3% |
| Abbott India Ltd. | 2.0% |
| Piramal Pharma Ltd. | 2.0% |
| Narayana Hrudayalaya Ltd. | 2.0% |
| Global Health Ltd. | 1.9% |
| Glaxosmithkline Pharmaceuticals Ltd. | 1.9% |
| Granules India Ltd. | 1.8% |
| Onesource Specialty Pharma Ltd. | 1.8% |
| Syngene International Ltd. | 1.1% |
| Natco Pharma Ltd. | 1.1% |
| Cohance Lifesciences Ltd. | 1.1% |
| Pfizer Ltd. | 1.1% |
| Poly Medicure Ltd. | 1.0% |
| Net Current Asset | -0.3% |
NameWeight
Laurus Labs Ltd.11.2%
Lupin Ltd.8.0%
Aurobindo Pharma Ltd.7.2%
Fortis Healthcare Ltd.7.1%
Glenmark Pharmaceuticals Ltd.5.6%
Alkem Laboratories Ltd.4.7%
Biocon Ltd.4.4%
Ipca Laboratories Ltd.4.1%
Mankind Pharma Ltd.4.1%
Gland Pharma Ltd.3.5%
Aster DM Quality Care Ltd.3.0%
Sai Life Sciences Ltd.3.0%
Neuland Laboratories Ltd.3.0%
Krishna Institute of Medical Sciences Ltd3.0%
Acutaas Chemicals Ltd.2.5%
Wockhardt Ltd.2.3%
Ajanta Pharma Ltd.2.3%
Dr. Lal Pathlabs Ltd.2.3%
Abbott India Ltd.2.0%
Piramal Pharma Ltd.2.0%
Narayana Hrudayalaya Ltd.2.0%
Global Health Ltd.1.9%
Glaxosmithkline Pharmaceuticals Ltd.1.9%
Granules India Ltd.1.8%
Onesource Specialty Pharma Ltd.1.8%
Syngene International Ltd.1.1%
Natco Pharma Ltd.1.1%
Cohance Lifesciences Ltd.1.1%
Pfizer Ltd.1.1%
Poly Medicure Ltd.1.0%
Net Current Asset-0.3%
Holdings Concentration
Total covered: 100%
Top 1–5
5 holdings
39.1%
39%
share
Top 6–10
5 holdings
20.8%
21%
share
Top 11–20
10 holdings
25.4%
25%
share
Beyond 20
10 holdings
14.9%
15%
share
Market Cap Classification
Total
100%
allocation
- Mid Cap67.8%
- Small Cap32.5%
- Mid Cap67.8%
- Small Cap32.5%
Advanced Ratios
| Alpha | -0.01 |
| Beta | 1.00 |
| Sharpe Ratio | 0.08 |
| Sortino Ratio | 0.13 |
| Treynor Ratio | 0.07 |
| Information Ratio | -0.10 |
| Upside Capture | 99.26% |
| Downside Capture | 101.81% |
Index Methodology
| Factor Basis | Size (Market Cap), Sector/Theme |
| What universe selected from? | Nifty MidSmallcap 400 index |
| Weightage? | Periodic Capped Free Float Market Cap Weighting |
| Stocks Included | Maximum 30 companies. Top 30 mid &/or smallcap healthcare stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 30 based on Free Float market cap (Healthcare industry, Mid & Small Cap only); Non F&O Stocks hitting circuit limit in 20% of trading days over last 6months |
| Factor Basis | Size (Market Cap), Sector/Theme |
| Universe | Nifty MidSmallcap 400 index |
| Weightage | Periodic Capped Free Float Market Cap Weighting |
| Stocks Included | Maximum 30 companies. Top 30 mid &/or smallcap healthcare stocks based on six-month average free-float market capitalization are selected |
| Exclusions | Stocks Excluded from Nifty 500, Stocks not meeting criteria of top 30 based on Free Float market cap (Healthcare industry, Mid & Small Cap only); Non F&O Stocks hitting circuit limit in 20% of trading days over last 6months |
Fund • Last updated: 12/10/2026